Thermo Fisher Scientific will invest an additional $2bn in the United States over the next four years, strengthening American innovation, manufacturing and economic competitiveness across the life sciences sector. As one of the largest manufacturers of medicines in the world, Thermo Fisher enables biopharma companies to develop and produce their medicines in America. These additional…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
